Nelson Hardiman is pleased to announced that, effective January 2016, the firm has “doubled down” on its leadership, adding three new partners, for a total of six.  The new partners include current NH attorneys, Rob Fuller and Aaron Lachant and a new addition, Zach Rothenberg, a seasoned business litigator. “Today marks a big step forward in our growth,” commented managing partner Harry Nelson. “Each of our new partners  is pivotal to our future leadership.” Rob Fuller, leads Nelson Hardiman’ transactional practice. A Fellow of the American College of Healthcare Executives and experienced hospital COO, Rob leverages decades of experience for our clients -- not only corporate governance and transactions, but reorganization, financing, credit facility, banking operations, bond issuance, and compliance issues.   Aaron Lachant, who holds the distinction of being the firm’s first “homegrown” partner,  leads the firm’s Regulated Substances practice, working with healthcare organizations and government on a wide range of regulatory compliance and business issues, including DEA, FDA, Medicare, and state regulations. Among other leadership roles, Aaron has worked closely with local governments in developing regulatory compliance programs and drafting legislation related to marijuana, and has represented providers in litigation involving both federal and state constitutional issues.   Zach Rothenberg, Nelson Hardiman’s newest addition, will add leadership to the firm’s  Litigation practice. As a partner in his former firm, litigation boutique Grodsky & Olecki LLP, Zach has represented healthcare industry clients and others in litigation of business disputes, including breach of contract, payment disputes, fraud, unfair competition, employment, and trade secret cases. “Zach is a phenomenal trial attorney,” commented partner John Mills. “We are thrilled to add another heavyweight to our litigation team.”